Skip to content

Author

Fatma Subaşı Turğut

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Extended-Release Guanfacine Hydrochloride is Safe and Effective as Mono- and Adjunctive Therapy in Children and Adolescents with ADHD: A Naturalistic, Multi-Center, Patient-Reported Outcome Measures-Based Study.

AIMS Attention-deficit hyperactivity disorder (ADHD) is characterized by impairing and age-inappropriate inattention, hyperactivity, and impulsivity. Extended-release guanfacine hydrochloride (GXR) is a selective α2A-adrenergic agonist approved as mono- and adjunctive therapy to psychostimulant medications for ADHD. Th...

M. Kutuk, A. Tufan, Fethiye Kılıçaslan et al. · 0 citations
Aug 2026

Serum HMGB1 and hs-CRP levels in adolescents with ADHD: a preliminary case-control study

The association between HMGB1 and communication problems suggests a possible relationship with specific neurodevelopmental dimensions; however, these findings are preliminary and hypothesis-generating and require replication in larger pediatric samples.

Fatma Subaşı Turğut, Yağmur Soysal, Neval Kızıl et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.